Journal Article

Endogenous estradiol contributes to vascular endothelial dysfunction in premenopausal women with type 1 diabetes

Blackburn, Marsha, Saad, Karim M., Derella, Cassandra C., Layman, Lawrence C., Nicholson, Matthew S., Elmarakby, Ahmed, Harris, Ryan A., Waller, Jennifer, Thomas, Jeffrey, Simon, Abigayle B.

2023

Overview

Background Endogenous estrogen is cardio-protective in healthy premenopausal women. Despite this favorable action of estrogen, animal models depict a detrimental effect of estradiol on vascular function in the presence of diabetes. The present study sought to determine the role of endogenous estradiol on endothelial function in women with type 1 diabetes. Method 32 women with type 1 diabetes (HbA 1c  = 8.6 ± 1.7%) and 25 apparently healthy women (HbA 1c  = 5.2 ± 0.3%) participated. Flow-mediated dilation (FMD), a bioassay of nitric-oxide bioavailability and endothelial function was performed during menses (M) and the late follicular (LF) phase of the menstrual cycle to represent low and high concentrations of estrogen, respectively. In addition, a venous blood sample was collected at each visit to determine circulating concentrations of estradiol, thiobarbituric acid reactive substances (TBARS), and nitrate/nitrite (NOx), biomarkers of oxidative stress and nitric oxide, respectively. Data were collected in (1) 9 additional women with type 1 diabetes using oral hormonal birth control (HBC) (HbA 1c  = 8.3 ± 2.1%) during the placebo pill week and second active pill week, and (2) a subgroup of 9 demographically matched women with type 1 diabetes not using HBC (HbA 1c  = 8.9 ± 2.1%). Results Overall, estradiol was significantly increased during the LF phase compared to M in both type 1 diabetes (Δestradiol = 75 ± 86 pg/mL) and controls (Δestradiol = 71 ± 76 pg/mL); however, an increase in TBARS was only observed in patients with type 1 diabetes (ΔTBARS = 3 ± 13 µM) compared to controls (ΔTBARS = 0 ± 4 µM). FMD was similar ( p  = 0.406) between groups at M. In addition, FMD increased significantly from M to the LF phase in controls ( p  = 0.024), whereas a decrease was observed in type 1 diabetes. FMD was greater ( p  = 0.015) in patients using HBC compared to those not on HBC, independent of menstrual cycle phase. Conclusion Endogenous estradiol increases oxidative stress and contributes to endothelial dysfunction in women with diabetes. Additionally, HBC use appears to be beneficial to endothelial function in type 1 diabetes.

• Publisher: BioMed Central,Springer Nature B.V,BMC
• Subject: 17β-Estradiol / Angiology / Animal models / Bioavailability / Cardiology / Contraception / Diabetes / Diabetes mellitus (insulin dependent) / Endothelial function / Estrogen / Estrogens / Laboratories / Medicine / Medicine & Public Health / Menstrual cycle / Menstruation / Nitric oxide / Oral contraceptives / Ovulation / Oxidative stress / Thiobarbituric acid / Veins & arteries